Phase 2 Study of KHK4577
NCT02004119 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 93
Last updated 2018-09-11
Summary
This study is an randomized double-blind placebo-controlled study to evaluate the efficacy and the safety of oral KHK4577 for 6 weeks in patients with atopic dermatitis. Pharmacokinetics of KHK4577 will also be assessed.
Conditions
Interventions
- DRUG
-
KHK4577
- DRUG
Sponsors & Collaborators
-
Kyowa Kirin Co., Ltd.
lead INDUSTRY
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- QUADRUPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 20 Years
- Max Age
- 64 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2013-11-30
- Primary Completion
- 2014-12-31
- Completion
- 2014-12-31
Countries
- Japan
Study Locations
More Related Trials
-
A Phase II, Placebo-controlled Trial Evaluating the Efficacy of Antroquinonol in Patients With Atopic Dermatitis
NCT04110873 ·Status: TERMINATED ·Phase: PHASE2
-
Study of an Anti-OX40 Monoclonal Antibody (KHK4083) in Subjects With Moderate to Severe Atopic Dermatitis
NCT03703102 ·Status: COMPLETED ·Phase: PHASE2
-
Oral DS107 in Moderate to Severe Atopic Dermatitis
NCT02211417 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of KT-621 Administered Orally to Participants With Moderate to Severe Atopic Dermatitis
NCT07217015 ·Status: RECRUITING ·Phase: PHASE2
-
Study to Evaluate Long-Term Safety of ASN002 in Subjects With Moderate to Severe Atopic Dermatitis
NCT03654755 ·Status: TERMINATED ·Phase: PHASE2
-
Effect of OC000459 on Moderate to Severe Atopic Dermatitis
NCT02002208 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluate the Efficacy and Safety of XKH001 Injection in Patients With Moderate-to-Severe Atopic Dermatitis
NCT07054736 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Efficacy and Safety of Orally Administered DS107 in Adult Patients With Moderate to Severe Atopic Dermatitis
NCT03817190 ·Status: TERMINATED ·Phase: PHASE2
-
A Study to Evaluate the Safety and Efficacy of PAC-14028 Cream in Adults With Atopic Dermatitis
NCT02757729 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Evaluate JYP0061 Tablets in Patients With Moderate-to-severe Atopic Dermatitis
NCT06158490 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE2
-
Phase 2a Study to Assess the Efficacy,Safety and Tolerability of GIA632 in Adult Participants With Moderate to Severe Atopic Dermatitis
NCT07220577 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Safety and Efficacy of AN2728 Topical Ointment, 2% in Children, Adolescents, and Adults (Ages 2 Years and Older) With Atopic Dermatitis
NCT02118766 ·Status: COMPLETED ·Phase: PHASE3
-
A Phase 1 Study of KHK4083 in Subjects With Atopic Dermatitis
NCT03096223 ·Status: COMPLETED ·Phase: PHASE1
-
Study of Dupilumab Monotherapy Administered to Adult Patients With Moderate-to-Severe Atopic Dermatitis
NCT02277743 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Explore the Safety, Tolerability, Efficacy, and Pharmacokinetics of LT-002-158 Tablets in Chinese Adult Subjects With Atopic Dermatitis
NCT06931990 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1/PHASE2
-
A Study of QY201 Tablet in Subjects With Moderate to Severe Atopic Dermatitis
NCT05525715 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1/PHASE2
-
Study of KHK 4323 in Healthy Volunteers and Subjects With Atopic Dermatitis
NCT03846466 ·Status: TERMINATED ·Phase: PHASE1
-
Study in Healthy Participants and Participants With Moderate Atopic Dermatitis & Optionally, Moderate Psoriasis, and/or Mild Asthma
NCT04927195 ·Status: COMPLETED ·Phase: PHASE1
-
A Study To Evaluate ASN002 In Subjects With Atopic Dermatitis
NCT03139981 ·Status: COMPLETED ·Phase: PHASE1
-
A Randomized, Double-Blind Study to Evaluate the Safety and Efficacy of 2 Doses of S-777469 in Patients With Atopic Dermatitis
NCT00703573 ·Status: COMPLETED ·Phase: PHASE2
-
Phase I Study of DS-2741a in Healthy Volunteers and Participants With Atopic Dermatitis
NCT04211415 ·Status: TERMINATED ·Phase: PHASE1
-
A Study Investigating the Effect of EDP1815 in the Treatment of Mild, Moderate and Severe Atopic Dermatitis
NCT05121480 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of Single and Multiple Ascending Doses of KBL697 in Healthy Subjects
NCT04056130 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of AK120 (IL-4Rα) in Healthy Subjects and Subjects With Moderate- to- Severe Atopic Dermatitis
NCT04256174 ·Status: COMPLETED ·Phase: PHASE1
-
Multiple Rising Dose Study of MK-6194 in Participants With Atopic Dermatitis (MK-6194-008)
NCT05450198 ·Status: COMPLETED ·Phase: PHASE1